Global Demand for Mucopolysaccharidosis Therapies Market 2036

Feb 12 · 3 min read · According to FutureWise analysis, the Mucopolysaccharidosis Market in 2026 is US$3.27 billion, and is expected to reach US$6.19 billion by 2036 at a CAGR of 6.59%. Mucopolysaccharidosis (MPS) refers to a group of rare metabolic disorders caused by th...